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Goals of Initiative 
To initiate a national program in Low Temperature Plasma (LTP) to take advantage of the 
research opportunities of 3 rapidly growing areas (nanomaterial plasma synthesis, plasma 
medicine, microelectronics). The main theme is to achieve a fundamental understanding of 
Low Temperature Plasmas as they are applied to these different applications. This 
understanding will allow U.S. industry to meet the challenges of international competition. 
 
Programmatic Benefit 
The programmatic benefit of this initiative is that a fundamental understanding of the 
plasmas as they are applied to the areas of nanomaterial plasma synthesis, plasma 
medicine, and microelectronics will be developed. This will eventually replace the current 
Edisonian approach to applications research that is costly and inefficient. This is a major 
challenge because Low Temperature Plasmas are complex. They have low ionization and 
therefore neutrals, electrons, and ions interactions need to be understood. In all three of 
these application areas plasma chemistry plays a major role. In many cases the plasmas are 
not in equilibrium, not Maxwellian, and radiation effects are important. Furthermore, at low 
pressures the plasma mean free path or energy relaxation length is longer than the system 
size. Therefore, the boundary conditions impact the plasma volume of the system. 
 
More importantly the initiative addresses the critical needs of the U.S. microelectronics 
industry, see white paper by microelectronics industry leaders [1]. The research needs for 
microelectronics have rapidly changed over the last 5 – 10 years. Where the US once 
dominated in the production of semi-conductor devices, now South Korea leads the world. 
Specifically, Samsung leads Intel in sale of such devices. Furthermore, there are concerns of 
state sponsored initiatives by China to modernize its economy, increase productivity, and 
use innovation to create economic growth. The initiative Made-In-China (MIC) 2025, looks to 
use innovation for future growth. In particular, China is targeting key industries to provide 
innovation including the microelectronics industry. An example of China becoming the leader 
of high-value manufacturing is their semiconductor purchases. In 2003 China was similar to 
the US (19.4% US, 18.5% China) in the purchase of semiconductors for the products it sold, 
but in 2019 the US has fallen to 11.9% and China dominates by consuming 60.5% of the 
world market [2]. These semiconductors are in the products China manufactures and sells to 
the world. The 2025 initiative has its goal to move China from being the largest consumer of 
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semiconductors to becoming the largest manufacturer of semiconductors. Microelectronics is 
nearly a $2 T/year industry. 
 
The US program should invigorate LTP research at the universities and national labs into a 
sustained program to develop plasma manufacturing techniques and understanding of the 
plasma conditions that are the basis of these manufacturing techniques. This joint 
partnership should not exist just for the short period of time needed to meet the immediate 
international challenge but should be sustained to continue to promote innovations and 
maintain our leadership of the field. At the moment, DOE’s budget in LTP is on the order of 
$4M/year. NSF does not support LTP with any focused programs. This is in contrast to the 
$Bs invested by industry for their internal research and the gross sales of the 
microelectronics sector of $2 T/year. The government is overlooking this threat to the US 
economy, military superiority, and US jobs. The 2010 Decadal Report on Plasma Science 
recognized the lack of sustained support and lack of stewardship for Low Temperature 
Plasma research. The modest response of the government has been is insufficient to meet 
the international challenge. The size of the current market warrants a government program 
($100 M/year) in LTP to promote and protect US interests similar to the programs set up to 
protect medical science and pharmaceuticals industries by the NIH (>$20 B/year); exascale 
computing (>$500 M) for an industry that is expected to emerge shortly, but currently does 
not generate substantial sales; and material science by BES of OS ($1.1 B/year). This 
initiative should not be funded at the expense of other important plasma application (e.g. 
domestic fusion energy research, ITER). 
 
While plasma medicine is a new scientific field there are several established international 
research groups working on the frontline. For instance, in Germany INP Greifswald 
University is supported at multimillion level by German Government leading to INP 
leadership in cold plasma medical devices development, and standardization acceptance by 
medical community. In South Korea, Kwanwoon University is developing a cancer therapy 
based on cold plasma. They focus on biological effects as well as on engineering aspects of 
cold plasma devices. South Korea government support is at the level of $25m over 5 years. 
Similarly in Japan, Nagoya University group of Prof. M. Hori is developing plasma sources 
and performing in vivo studies and is well supported by Japanese government. In summary, 
there is coordinated research effort supported by governments in Germany, Korea and 
Japan in plasma medicine area, while there is no such program in US. 
 
Description of the Initiative 
Long-term investments on all three areas of Low Temperature Plasma: plasma synthesis of 
nanomaterials, plasma medicine, and microelectronics. 
 
Specifically: 
 
1. Nanomaterial plasma synthesis 
LTP can be used to produce metal nanoparticles, for example, by decomposing a metal-
containing gas, or to produce nanoparticles of the IV,V-group of nonmetallic elements of the 
periodic table (C, B, Si, N etc.). Nanoparticles are synthesized by either decomposing 
background gases or ablating electrodes containing these elements. The plasma 
environment offers a number of attractive properties that allow for the generation of 
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nanoparticle materials that are hard to produce by other means. The negative nanoparticle 
charge in plasmas suppresses particle coagulation and enables the synthesis of highly 
monodisperse nanoparticles. The negative charge also confines nanoparticles in the reactor, 
very different from neutral gas synthesis, in which particles are often quickly lost to the 
reactor walls due to diffusion. These unique capabilities of LTP have already enabled 
technological advances such as the generation of nanometer-sized metal particles, 
diamonds, stable silicon-nanocrystal anodes for lithium ion batteries, high-mobility 
transparent conductive oxide films based on zinc oxide nanocrystals etc. [3].  
 
Low Temperature Plasma that create nanomaterials can operate at temperatures near 
10,000 degrees K and provide high fluxes of chemically active species that can trigger new 
chemical pathways for efficient nucleation and growth of nanomaterials with specific 
compositions. Even though plasma synthesis of nanomaterials has significantly higher 
growth rates compared to Chemical Vapor Deposition, its lack of selectivity limits its 
adaptation [4].  High selectivity requires developing new more sophisticated fabrication 
conditions beyond the conventional plasma approaches. For example, Kim et al. [5] 
manufactured BN nanotubes (NT) using a RF plasma with addition of hydrogen.  The 
presence of hydrogen is believed to promote the formation of BN precursors such as NH and 
BH radicals and greatly enhance production of BN nanotubes [5]. This is just one of 
examples of importance of plasma chemistry in formation of nanomaterials. These results 
predict possible new mechanisms for high temperature synthesis methods such as plasma 
and lasers, and suggest the possibility of controlling the synthesis process and the types of 
synthesized nanostructures through the addition of hydrogen. 
 
There are a number of different proposed growth mechanisms for the synthesis of Boron 
Nitride (BN) nanostructures. Using quantum-classical Molecular Dynamics (MD), the 
synthesis of BNNTs and other BN nanostructures was simulated [6,7,8]. BN molecules can 
form BN cages without the presence of a boron NP to act as a catalyst at a temperature of 
2000K, which is within the temperature range of the proposed synthesis region in the plasma 
torch experiments by direct self-organization of BN diatomic molecules. It was also found 
that BN nanostructures can be synthesized by bombarding a boron nanoparticle with BN 
diatomic molecules or nitrogen atoms [8]. However, if hydrogen-rich molecules such as NH3 
or HBNH are used as a feedstock, stable two-dimensional nanoflake structures are only 
formed [8]. In addition, BN nanotubes growth was demonstrated from a short BN nanotube 
template at 2500 K [8]. However, how this template can be created in practice is not clear.  
 
Additional MD simulations [7] seem to suggest that for formation of BNNT a small droplet of 
boron in the temperature range ~ 2000-2500 K has to absorb enough nitrogen to form a 
boron nitride cap. Further growth of both boron droplet (due to boron flux onto the droplet) 
and BNNT (due to nitrogen flux onto the boron droplet) can occur as soon as BN cap is 
formed. The length of BNNT will be determined by how much nitrogen flux can incorporate 
into BNNT root, similar to growth of carbon nanotubes (CNT). 
 
However, these MD simulations have been performed with pre-defined gas composition; in 
particular, pure BN molecules gas and pure borazine gas were separately considered. In 
practice, the feedstock material is introduced into plasma, evaporates, and is subsequently 
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transported to the reaction zone. In this zone, under definite temperature conditions, boron 
starts to condense and nanotubes form. In this process, composition of the gas mixture 
cannot be arbitrary prepared; it is determined by chemical reactions between the gas 
species. What can be controlled is feedstock material, pressure and temperature within the 
system and buffer gas composition. Molecular dynamics simulations are not capable of 
modeling long timescale processes of material evaporation, cooling and condensation; 
different method should be applied to determine actual gas mixture composition at the 
nanoparticles growth [9,10].  
 
Other important synthesis applications include synthesis of 2D materials and thin films, 
diamond-like materials, including diamond defects for quantum computing, and porous 
materials to name a few [11]. In all these applications plasma is often used for synthesis, 
and plasma properties are poorly understood. 
 
Additional funding is needed to understand and develop reliable plasma nano-material 
synthesis techniques with high selectivity for all materials. To achieve this it is important to 
have a large array of advanced plasma diagnostics. The first steps towards in situ diagnosis 
of the nucleation and growth of nanoparticles in plasma have already been completed (see, 
for example in Ref. [12]). The next steps should include diagnosing the particle charging and 
structure of nanoparticles in situ. Integrated modeling including molecular dynamics, 
thermodynamics, fluid modeling of plasma composition, should be performed in a self-
consistent manner and validated by extensive experimental data obtained with in situ 
diagnostics to achieve understanding of synthesis and selectivity. 
 
2. Plasma medicine 
 
Plasma medicine research is just in its infancy but is a rapidly growing field of medical 
treatment, with the number and type of medical applications growing annually, such as 
dentistry, cancer treatment, wound healing, antimicrobial and surface sterilization. Plasma 
medicine is a new, largely unexplored multi-disciplinary scientific field that integrates physics, 
chemistry, engineering and biology [13,14,15,16,17,18,19,20,21,22]. It focuses on the 
biomedical technology based on interaction of cold atmospheric plasma with cells alone and 
within the context of living tissue. Controlling non-thermal plasma interaction with biological 
objects (biological liquids, cells, tissues, food, plants, agricultural products) is one of the 
most important aspects of the plasma application in biomedical field. Furthermore, LTP 
promotes muscle and blood vessel regeneration, and osteointegration is also being 
investigated. With the rapid increase in new medical applications, there is development of 
new devices and systems for treatment, and wider clinical applications. There is a wide 
range of plasma sources that allow customization of specific applications. Plasma medicine 
is a powerful tool in medical research. Besides developing plasma medical applications, 
additional funding is required to understand the mechanisms for how plasma triggers 
biological processes to heal wounds, kill cancer cells preferentially, and kill bacteria [20]. 
 
3. Microelectronics 
 
What is needed is a joint government-private sector research initiative to develop the 
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techniques required to make micro-chips utilizing 10 nm lithography and meet the challenge 
of international mobilization to also develop alternative techniques, see Appendix for more 
information. In semiconductor processing and equipment, there are huge emerging issues 
related to shrinking critical dimension and next generation device structure, such as 3D 
DRAM, 3D V-NAND, 3D FET (gate-all-around nanowire and nanosheet FET) [23,24,25]. It is 
true that even they (current leading semiconductor device and equipment companies) do not 
have a clear alternative for these issues. These can be solved via modern LTP techniques 
[26,27,28], such as high aspect ratio & atomic layer plasma surface interactions, EUV 
plasma source, etc.  
 
As noted above, the US program should invigorate LTP research at the universities and 
national labs into a sustained program to develop plasma manufacturing techniques and 
understanding of the plasma conditions and complex plasma-surface interactions that are 
the basis of these manufacturing techniques. This joint partnership should not exist just for 
the short period of time needed to meet the immediate international challenge but should be 
sustained to continue to promote innovations and maintained our leadership of the field. The 
program needs to be on a scale of $100’s M/year funding for the national labs and 
universities. The universities are well suited to develop these new processing techniques 
and for the workforce development. The national labs are well suited to characterize and 
evaluate LTP manufacturing equipment for industry and provide a comprehensive study of 
the plasmas and complex plasma-surface interactions that are the basis of the 
manufacturing techniques. This initiative should not be funded at the expense of other 
plasma applications, fusion energy research (e.g. domestic program and ITER). 
 
US Leadership and Global Context 
 
The initiative is focused upon the US achieving the lead in nanomaterial plasma synthesis 
and plasma medicine. These are emerging fields that have many opportunities, but there is a 
lack of fundamental understanding of the processes. 
 
Most importantly, the initiative is critical for the U.S. microelectronics industry. It focuses on 
the US regaining its lead in production of semiconductors from South Korea. In addition, the 
initiative will lead the way in the development of the next generation of computer chips based 
upon lithography at 10 nm and component sizes approaching 1 nm. The initiative is in direct 
response to the Made in China 2025 economic initiative. The US needs to support LTP 
research in the same manner it supports the medical and pharmaceutical fields with NIF 
funding, Exascale computing with its own initiative, and material science research with BES 
funding. Without this initiative and focus on Low Temperature Plasma the U.S. is at risk of 
losing its leadership position in microelectronics and not being competitive [29] in the 
developing fields of nanomaterial plasma synthesis and plasma medicine. 
 
Timeline of the Initiative 
(1) 1-2 years to form a strategy with consensus from the community and agreement with 
other related agencies 
(2) 5-10 years to develop and establish this initiative 
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